Guoqiang Chen

30PUBLICATIONS
97CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisPreventative health careCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 24, 2026
Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

|Jun 10, 2026
The disulfonic acid ANDS disrupts ANP32B-p53 interaction to suppress chronic myeloid leukemia.

|Mar 04, 2026
Cell-free chromatin state tracing reveals disease origin and therapy responses.

Xubin Chen, Xiaoxuan Meng, Weilong Zhang

|Feb 02, 2026
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

Zhe Huang, Liang Zeng, Zhaohui Ruan

|Feb 18, 2025
Author Correction: Fetal hepatocytes protect the HSPC genome via fetuin-A.

Xiao-Lin Guo, Yi-Ding Wang, Yan-Jun Liu

|Feb 06, 2025
Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload.

Wan Fu, Jianghuang Wang, Tianyu Li

Pageof 5

Frequent Collaborators

5 joint publications

Shao-Ming Shen

5 joint publications

Jinke Cheng

4 joint publications

Jianxiu Yu

3 joint publications

Jian Zhang